Role of immunotherapy and co-mutations on KRAS-mutant non-small cell lung cancer survival.

MLA

Amanam, Idoroenyi, et al. “Role of Immunotherapy and Co-Mutations on KRAS-Mutant Non-Small Cell Lung Cancer Survival.” Journal of Thoracic Disease, vol. 12, no. 9, Sept. 2020, pp. 5086–95. EBSCOhost, https://doi.org/10.21037/jtd.2020.04.18.

APA

Amanam, I., Mambetsariev, I., Gupta, R., Achuthan, S., Wang, Y., Pharaon, R., Massarelli, E., Koczywas, M., Reckamp, K., & Salgia, R. (2020). Role of immunotherapy and co-mutations on KRAS-mutant non-small cell lung cancer survival. Journal of Thoracic Disease, 12(9), 5086–5095. https://doi.org/10.21037/jtd.2020.04.18

Chicago

Amanam, Idoroenyi, Isa Mambetsariev, Rohan Gupta, Srisairam Achuthan, Yingyu Wang, Rebecca Pharaon, Erminia Massarelli, Marianna Koczywas, Karen Reckamp, and Ravi Salgia. 2020. “Role of Immunotherapy and Co-Mutations on KRAS-Mutant Non-Small Cell Lung Cancer Survival.” Journal of Thoracic Disease 12 (9): 5086–95. doi:10.21037/jtd.2020.04.18.